tiprankstipranks
Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ:VNDA

Vanda (VNDA) Stock Price & Analysis

359 Followers

VNDA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.30 - $7.00
Previous Close$3.81
Volume1.12M
Average Volume (3M)1.00M
Market Cap
$218.64M
Enterprise Value-$162.62M
Total Cash (Recent Filing)$388.26M
Total Debt (Recent Filing)$7.01M
Price to Earnings (P/E)87.2
Beta0.67
May 01, 2024
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding57,537,499
10 Day Avg. Volume1,005,744
30 Day Avg. Volume1,002,050
Standard Deviation0.13
R-Squared0.10
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.52
Price to Sales (P/S)4.84
Price to Cash Flow (P/CF)-13.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.84
Enterprise Value/Gross Profit-0.91
Enterprise Value/Ebitda-18.17
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

29.45%23.61%28.80%18.15%
29.45% Insiders
28.80% Other Institutional Investors
18.15% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

VNDA FAQ

What was Vanda Pharmaceuticals Inc.’s price range in the past 12 months?
Vanda Pharmaceuticals Inc. lowest stock price was $3.29 and its highest was $7.00 in the past 12 months.
    What is Vanda Pharmaceuticals Inc.’s market cap?
    Currently, no data Available
    When is Vanda Pharmaceuticals Inc.’s upcoming earnings report date?
    Vanda Pharmaceuticals Inc.’s upcoming earnings report date is May 01, 2024 which is in 34 days.
      How were Vanda Pharmaceuticals Inc.’s earnings last quarter?
      Vanda Pharmaceuticals Inc. released its earnings results on Feb 07, 2024. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.09 by $0.05.
        Is Vanda Pharmaceuticals Inc. overvalued?
        According to Wall Street analysts Vanda Pharmaceuticals Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Vanda Pharmaceuticals Inc. pay dividends?
          Vanda Pharmaceuticals Inc. does not currently pay dividends.
          What is Vanda Pharmaceuticals Inc.’s EPS estimate?
          Vanda Pharmaceuticals Inc.’s EPS estimate is $0.05.
            How many shares outstanding does Vanda Pharmaceuticals Inc. have?
            Vanda Pharmaceuticals Inc. has 57,537,500 shares outstanding.
              What happened to Vanda Pharmaceuticals Inc.’s price movement after its last earnings report?
              Vanda Pharmaceuticals Inc. reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.09. Following the earnings report the stock price went up 11.813%.
                Which hedge fund is a major shareholder of Vanda Pharmaceuticals Inc.?
                Among the largest hedge funds holding Vanda Pharmaceuticals Inc.’s share is Graham Capital Management, L.P.. It holds Vanda Pharmaceuticals Inc.’s shares valued at 107K.
                  ---

                  Company Description

                  Vanda Pharmaceuticals Inc.

                  Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Cormedix
                  Eagle Pharmaceuticals
                  FibroGen
                  Amicus
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis